Ghana: FDA Resolves to Address Complaints On Coagulated Milk

The Food and Drugs Authority (FDA) says it has put in place measures to address consumer complaints on coagulated milk products from Nestle Ghana Limited.

The authority had indicated that it has in receipt of consumer complaints, and in line with best regulatory practices requested Nestle to respond to the complaints and initiate a recall of affected batches.

Mrs Delese Darko, Chief Executive Officer (CEO) of the Authority, in a statement signed and issued yesterday and copied to the Ghanaian Times in Accra outlined some comprehensive regulatory action undertaken to ensure that any safety concerns to consumers were immediately detected and dealt with.

She said a complete Good Manufacturing Practice (GMP) inspection of Nestle’s manufacturing facility at Tema to establish the root cause of the coagulation of the evaporated milk had been done.

Mrs Darko also stated that a review of analytical reports, documentation of raw and packaging materials, and product analyses had been done.

The FDA CEO again said “a microbial analysis was conducted on samples taken from the manufacturing facility and complaint samples at the FDA Laboratory. Results from the analysis indicated that there was no microbial contamination of samples and therefore there is no food safety issue with the said coagulated milk products from Nestle.”

She said that analysis confirmed that there was no leaching of dangerous chemicals from the inner (lacquer) lining into the milk product.

Mrs Darko, therefore, noted that the root cause analysis done indicated that the skimmed milk powder (raw material) used to produce the milk complained of has poor heat stability.